Literature DB >> 29613883

Long-Term Course of Shoulders After Ultrasound Therapy for Calcific Tendinitis: Results of the 10-Year Follow-Up of a Randomized Controlled Trial.

Karin Pieber1, Martina Grim-Stieger, Franz Kainberger, Martin Funovics, Karl-Ludwig Resch, Thomas Bochdansky, Eleonore Pablik, Gerold Ebenbichler.   

Abstract

OBJECTIVE: The aim of the study was to follow both the structure- and function-related long-term course of shoulders that had been treated with therapeutic ultrasound for symptomatic calcific tendinitis.
DESIGN: This is a long-term follow-up of 45 shoulders (37 patients) that had been treated for symptomatic calcific tendinitis with either a series of ultrasound or sham ultrasound 10 yrs ago. The main outcome variables were presence of calcium deposits and subacromial impingement on standardized x-ray imaging, shoulder symptoms (Binder score), and function (Constant score).
RESULTS: At 10 yrs, a similar proportion of calcium deposits had resolved in 78% of the originally ultrasound treated compared with 83% of sham-treated shoulders, whereas at 9 mos, significantly more calcium deposits had been resolved in the ultrasound group (P = 0.045). Relative to baseline, shoulder symptoms and function had significantly improved at both the 10-yr and 9-mo follow-up examinations with no significant differences between groups. Regular sports performance at baseline predicted a favorable long-term outcome.
CONCLUSIONS: Symptomatic calcific tendinitis of the shoulder has a good likelihood to completely resolve in the long term. Treating the calcium deposit effectively, however, may not be causal to the recovery from symptoms and function in calcific tendinitis.

Entities:  

Mesh:

Year:  2018        PMID: 29613883     DOI: 10.1097/PHM.0000000000000939

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  1 in total

1.  Efficacy of ultrasound therapy for the treatment of lateral elbow tendinopathy (the UCICLET Trial): study protocol for a three-arm, prospective, multicentre, randomised controlled trial.

Authors:  Ziyang Sun; Shuai Chen; Weixuan Liu; Guixin Sun; Junjian Liu; Jian Wang; Wei Wang; Yuanyi Zheng; Cunyi Fan
Journal:  BMJ Open       Date:  2022-01-17       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.